ChemoAlert is a surface sampling kit used by hospitals, pharmacies, infusion centers and anyone who handles chemotherapy drugs in the U.S. and Canada, to regularly test for drug residue. If gone unnoticed, workers may be exposed to antineoplastic drugs, which could be harmful to health over time. ChemoAlert was designed in compliance with USP <800> and NAPRA regulation, which drive the safe handling of hazardous drugs (HD) to help you safeguard your healthcare workers. To comply with these regulations, testing is recommended every 6 months in North America.

WHAT DOES THE CHEMOALERT KIT INCLUDE?

The kit, proprietary to Bureau Veritas, includes everything you need to collect a viable HD sample: swabs, vials, templates, wetting agent, gloves and an ice pack to maintain sample integrity during shipping and storage.

WHICH HAZARDOUS DRUGS CAN BE ANALYZED USING CHEMOALERT?

A single swab can detect up to 19 HDs, including platinum-containing drugs:

5-Fluorouracil	Doxorubicin	Irinotecan
Carboplatin	Epirubicin	Methotrexate
Cisplatin	Etoposide	Oxaliplatin
Cyclophosphamide	Etoposide Phosphate	Paclitaxel
Cytarabine	Gemcitabine	Vinblastine Sulfate
Decitabine	Ifosphamide	Vincristine
Docetaxel

As each kit includes 10 vials and swabs, you can detect a combination of up to 19 HDs across multiple surfaces using just one kit. With a detection limit of only 5 ng/sample, ChemoAlert also offers superior analytical sensitivity and specificity compared to similar products.

WHAT DOES THE CHEMOALERT KIT INCLUDE?

WHICH HAZARDOUS DRUGS CAN BE ANALYZED USING CHEMOALERT?

Video on how to use